[1] |
ZHAO Xuan, GUO Jing, CHEN Ning, MEI Long, ZHENG Tingting, ZHANG Lifang, ZHANG Wei.
Discuss the safety management of medical toxic drugs in medical institutions
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 705-708.
|
[2] |
ZHENG Yujing, ZHAO Zinan, JIN Pengfei, ZHAO Fei, HU Xin, ZHANG Yatong.
Active monitoring of adverse reactions of capecitabine-induced hand-foot syndrome based on the hospital information system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 441-443.
|
[3] |
GENG Hongjiao, WANG Lianxin, XIE Yanming.
Pharmacovigilance of Chinese Medicine in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 552-555.
|
[4] |
SA Rina, ZHANG Bing, LIN Zhijian, WANG Xiaofang, ZHANG Xiaomeng.
Pharmacovigilance of Traditional Chinese Medicine in Pharmaceutical Care in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(5): 422-426.
|
[5] |
FENG Yanan, LIU Xinxin, LI Yonghui, WANG Fang, GUO Ruifeng.
Challenges to Pharmacovigilance by Medical Institutions under the New Drug Administration Law
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 572-573.
|
[6] |
HUANG Yuan, WANG Chenggang, WU Shifu, WANG Ling, TIAN Yuejie, WU Chen, WANG Xiaojun.
Drug Abuse Monitoring Models in Medical Institutions in China
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 607-612.
|
[7] |
SHI Bing-juan.
Thinking on Improving and Guaranteeing the Quality of Traditional Chinese Medicine Preparations in Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(5): 276-279.
|
[8] |
ZHAO Xia, LENG Meiling, WANG Peng, LI Xinling, CAO Lujuan, TIAN Chunhua, LIU Cuili.
Research on Current Status and Countermeasures of Information Collection on Adverse Drug Reactions by Drug Manufacturers from Medical Institutions in China
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 652-657.
|
[9] |
LI Ang, ZHANG Bing, ZHANG Xiao-meng, SUN Xiao-xia, YANG Xue, LI Fan.
Investigation on the Situation of Cognition and Reporting of Adverse Drug Reactions in 1 109 Basic Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(5): 289-294.
|
[10] |
TIAN Chun-hua .
Thinking to Promote Adverse Drug Reaction Monitoring Work of Medical Institutions
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(5): 272-274.
|
[11] |
JIN Feng ,QU Yi ,FAN Ruo-xi ,LI Xin -ling.
Analysis and Prospect of the Present Situation of Grassroots Level Adverse Drug Reaction Monitoring System Construction in Our Country
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(5): 275-278.
|
[12] |
ZHANG Xue-mei, GUO Jia-dong, FENG Bian-ling, YANG Shi-min.
Investigation on Work State of Adverse Drug Reaction Reporting in Some West Provinces
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(12): 740-743.
|
[13] |
ZHANG Xue-mei, GUO Jia-dong, FENG Bian-ling*, YANG Shi-min.
Study on the ADR Monitoring of Medical Institutions of 6 Provinces in China
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(10): 603-606.
|
[14] |
MA Ning, ZHAI Wei, ZHOU Li-xing, ZHANG Li-ming.
The Status Assessment of Medical Device Adverse Event Monitoring System in the Third Grade Medical Institutions of Beijing
[J]. Chinese Journal of Pharmacovigilance, 2012, 9(8): 464-468.
|
[15] |
LIU Cui-li, TIAN Chun-hua, FENG Hong-yun.
How Medical Institutions to Do Adverse Drug Reaction Monitoring Well
[J]. Chinese Journal of Pharmacovigilance, 2012, 9(4): 224-226.
|